04/14/2016 - 12:40pm

In 2015, the OGD granted 580 approvals and 146 tentative approvals, including 99 in December alone – the largest number of drug approvals given out in a single month. 

04/13/2016 - 12:17pm

Biologic medications — nine of which were among the Food and Drug Administration’s approvals in 2015 — constitute a big portion of the specialty market.

04/13/2016 - 12:17pm

In the last two years, the FDA has broken its record for the approval of orphan drugs to treat diseases that affect 200,000 or fewer people.

04/13/2016 - 12:17pm

It’s no secret that the category of drugs drawing the most attention — and money — in recent years has been specialty pharmacy.

04/13/2016 - 12:16pm

In February, CEO Update named National Association of Chain Drug Stores president and CEO Steve Anderson Trade Association CEO of the Year. DSN looks at some of the more important work accomplished by NACDS under Anderson’s leadership.

04/13/2016 - 11:00am
CRN has formed a working group to resolve the specifics of the product registry, which is anticipated will contain multiple tiers of product information.
04/13/2016 - 9:52am

The legislation, advocated by both retail pharmacy and the pharma industry, would advance collaboration among health and enforcement authorities to achieve drug abuse solutions that maintain patients’ legitimate access to medications.

04/07/2016 - 12:06pm

The letter points out that copay increases place financial burdens on TRICARE beneficiaries and restrict patient access. In addition, restricting patient access could adversely impact medication compliance and actually increase health costs. 

04/06/2016 - 10:35am

In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.